Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net income	$ 49.7	$ 20.4
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	43.8	48.7
Accelerated depreciation	0.5	1.8
Share-based compensation expense	3.3	3.2
Changes in assets and liabilities:
Increase in accounts receivable	(81.9)	(40.2)
(Increase) decrease in inventories	(12.3)	3.8
Increase (decrease) in accounts payable	1.7	(9.9)
Accrued expenses and other assets and liabilities, net	(47.6)	(50.0)
Net cash used by operating activities	(42.8)	(22.2)
Investing activities
Capital expenditures	(24.4)	(20.3)
Net proceeds from divestiture	0.0	7.3
Proceeds from plant closures	2.0	0.0
Other investing activities	(2.1)	0.0
Net cash used by investing activities	(24.5)	(13.0)
Financing activities
Cash dividends paid	(23.5)	(22.5)
Repayment of long-term debt	(2.7)	(0.8)
Other financing activities	(1.9)	(2.3)
Net cash used by financing activities	(28.1)	(25.6)
Effect of exchange rate changes on cash	(6.1)	2.4
Decrease in cash and cash equivalents	(101.5)	(58.4)
Cash and cash equivalents at beginning of year	545.8	641.1
Cash and cash equivalents at end of period	$ 444.3	$ 582.7